Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print RSS Feed

Breaking News

Related Searches: Industry News

March 1, 2010
Merck KgA has made an offer of $7.2 billion, including assumption of $1.2 billion in debt, to acquire Millipore  Read More »

February 26, 2010
iBio, Inc. has agreed to license its iBioLaunch technology platform and provide technology transfer services to G-Con, LLC for the development and manufacture of plant-expressed influenza vaccines at a new facility in Bryan, TX.  Read More »

February 26, 2010
Regulus Therapeutics has entered into a new collaboration with GlaxoSmithKline to develop and commercialize microRNA therapeutics targeting microRNA-122 in Hepatitis C Viral infection (HCV).  Read More »

February 26, 2010
Peck to succeed Ringo as SVP, worldwide business development, strategy and innovation  Read More »

February 26, 2010
New service takes clients to India to scout CRO and CMO providers  Read More »

February 25, 2010
Pfizer received approval from the FDA for Prevnar 13, a 13-valent pneumococcal conjugate vaccine.  Read More »

February 25, 2010
Genentech’s Phase III study of Avastin (bevacizumab) plus chemotherapy, followed by maintenance use of Avastin alone, increased progression-free survival (PFS) in women with previously untreated advanced ovarian cancer, compared to chemotherapy alon  Read More »

February 25, 2010
In the quarter, income from operations was up 12% to $29.6 million and for the year was $116.3 million (+17%).  Read More »

February 24, 2010
WuXi PharmaTech received a certificate of GMP compliance from the Medical Products Agency (MPA) of Sweden, on behalf of the European Medicines Agency (EMEA), for its cGMP drug product manufacturing and analytical testing facilities in Shanghai.  Read More »

February 24, 2010
Bilcare Technologies has launched its nonClonable patient safety system in the U.S. to help prevent counterfeit drugs and enhance patient compliance.  Read More »

February 24, 2010
The Centers for Disease Control & Prevention (CDC) has selected Sentry BioPharma Services to store and distribute flu vaccine to support its national strategic reserve.  Read More »

February 24, 2010
Ocera Therapeutics has completed enrollment for its Phase IIb ASTUTE Study (AST-120 Used to Treat Hepatic Encephalopathy).   Read More »

February 23, 2010
Chiltern International and Charles River Laboratories have entered into a collaboration under which Chiltern Early Phase will partner with Charles River to conduct and support radiolabelled studies.  Read More »

February 23, 2010
Lee E. Babiss, Ph.D., has been appointed executive vice president of global laboratory services.   Read More »

February 23, 2010
PAREXEL International Corp. has opened a new early phase unit in Port Elizabeth, South Africa.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On